Condition: Chronic Myeloid Leukemia (CML) · Sponsor: University Hospital, Clermont-Ferrand
Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.
This description comes directly from the study's public registry record.
Lise Laclautre · 04 73 75 11 95 · promo_interne_drci@chu-clermontferrand.fr
Always discuss trial participation with your own doctor first.
| CH Annecy Genevois | Annecy, France | Recruiting |
| University Hospital, Caen | Caen, France | Recruiting |
| CHU Clemront-Ferrand | Clermont-Ferrand, France | Recruiting |
| Centre Hospitalier Emile Roux | Le Puy-en-Velay, France | Recruiting |
| University Hospital, Limoges | Limoges, France | Recruiting |
| Institut Paoli-Calmettes | Marseille, France | Recruiting |
| Centre Hospital, Nancy | Nancy, France | Recruiting |
| Bicetre Hospital | Paris, France | Recruiting |
| Hopital Paul Brousse | Paris, France | Recruiting |
| Rennes University Hospital | Rennes, France | Recruiting |
| Centre Hospitalier de Rochefort | Rochefort, France | Recruiting |
| Centre Hospitalier Universitaire de Saint Etienne | Saint-Etienne, France | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05963061